Dr. Marwan G. Fakih discussed the FDA approval of Lumakras with Vectibix for third-line treatment of KRAS G12C-mutated ...

Mumbai: The Brihanmumbai Municipal Corporation (BMC) is set to implement targeted next-generation sequencing for personalised ...

The platform enables direct, unbiased genome-wide identification and quantification of the exact position of double strand DNA breaks in edited cells.

Here we present a case of a patient with stage IV CD-74-ROS1 fusion NSCLC discovered initially with RNA next generation sequencing (NGS) who acquired ...

Today, the Chan Zuckerberg Initiative (CZI) launched the Billion Cells Project, an effort to generate an unprecedented one ...

Caris Life Sciences ® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, announced today ...

Robert F. Werner, the Chief Accounting Officer of Twist Bioscience Corp (NASDAQ:TWST), a $3.2 billion market cap biotechnology company with strong recent momentum showing a 43% return over the past ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

Tempus AI (TEM) is soaring 13% today after investment bank TD Cowen reinstated coverage of the shares with a Buy rating. TEM ...

The company reiterated its full-year 2025 guidance of 3% to 5% organic revenue growth and 300 basis points of adjusted EBITDA margin expansion. Multiomics is expected to grow in the low single digits, ...

Q1 2025 Earnings Conference Call February 5, 2025 8:30 AM ETCompany ParticipantsYvonne Perron - Vice President, FP&A ...